Correlation Between MGC Pharmaceuticals and Aion Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MGC Pharmaceuticals and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MGC Pharmaceuticals and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MGC Pharmaceuticals and Aion Therapeutic, you can compare the effects of market volatilities on MGC Pharmaceuticals and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MGC Pharmaceuticals with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of MGC Pharmaceuticals and Aion Therapeutic.

Diversification Opportunities for MGC Pharmaceuticals and Aion Therapeutic

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between MGC and Aion is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding MGC Pharmaceuticals and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and MGC Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MGC Pharmaceuticals are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of MGC Pharmaceuticals i.e., MGC Pharmaceuticals and Aion Therapeutic go up and down completely randomly.

Pair Corralation between MGC Pharmaceuticals and Aion Therapeutic

If you would invest  0.58  in Aion Therapeutic on August 30, 2024 and sell it today you would earn a total of  0.47  from holding Aion Therapeutic or generate 81.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

MGC Pharmaceuticals  vs.  Aion Therapeutic

 Performance 
       Timeline  
MGC Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MGC Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, MGC Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Aion Therapeutic 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

MGC Pharmaceuticals and Aion Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MGC Pharmaceuticals and Aion Therapeutic

The main advantage of trading using opposite MGC Pharmaceuticals and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MGC Pharmaceuticals position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.
The idea behind MGC Pharmaceuticals and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Valuation
Check real value of public entities based on technical and fundamental data
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world